14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMM.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Immutep Limited
(Updated on May 03, 2024)

Buy candidate since Apr 29, 2024 Loss -2.25% PDF

The Immutep Limited stock price gained 3.57% on the last trading day (Friday, 3rd May 2024), rising from $0.420 to $0.435. During the last trading day the stock fluctuated 5.95% from a day low at $0.420 to a day high of $0.445. The price has risen in 5 of the last 10 days and is up by 24.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 141 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.21 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.15% during the next 3 months and, with a 90% probability hold a price between $0.410 and $0.520 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMM.AX Signals & Forecast

The Immutep Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.431 and $0.387. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Immutep Limited has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 24, 2024, and so far it has fallen -3.33%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Immutep Limited stock

Immutep Limited finds support from accumulated volume at $0.420 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0250 between high and low, or 5.95%. For the last week, the stock has had daily average volatility of 5.76%.

Our recommended stop-loss: $0.415 (-4.65%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (IMM.AX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Immutep Limited to open at $0.433, and during the day (based on 14 day Average True Range), to move between $0.412 and $0.458, which gives a possible trading interval of +/-$0.0234 (+/-5.37%) up or down from last closing price. If Immutep Limited takes out the full calculated possible swing range there will be an estimated 10.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.445 (2.30%) than the support at $0.420 (3.45%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immutep Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immutep Limited stock to perform well in the short-term.

Current score: 2.768 Buy Candidate Unchanged

Predicted Opening Price for Immutep Limited of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$0.433 ( 0.383%) $0.435

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMM.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.458 5.36 %
R2 0.449 3.17 %
R1 0.443 1.81 %
Current price: 0.435
Support S1 0.424 -2.58 %
S2 0.418 -3.93 %
S3 0.408 -6.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0.450 3.45 %
R1 0.445 2.30 %
Current price 0.435
Support S1 0.420 -3.45%
S2 0.400 -8.05%
S3 0.355 -18.39%

FAQ

What is the symbol for Immutep Limited Stock and on which exchange is it traded?
The symbol for Immutep Limited is IMM.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Immutep Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immutep Limited stock to perform well in the short-term.

How to buy Immutep Limited Stock?
Immutep Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immutep Limited Stock.

What's the current price of Immutep Limited Stock?
As of the end of day on the May 03, 2024, the price of an Immutep Limited (IMM.AX) share was $0.435.

What is the 52-week high and low for Immutep Limited Stock?
The 52-week high for Immutep Limited Stock is $0.455 and the 52-week low is $0.225.

What is the market capitalization of Immutep Limited Stock?
As of the May 03, 2024, the market capitalization of Immutep Limited is 517.141M.

When is the next earnings date for Immutep Limited?
The upcoming earnings date for Immutep Limited is Jul 28, 2024.
Click to get the best stock tips daily for free!

About Immutep Limited

Immutep Limited Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, wh... IMM.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT